Cancer Cells Shapeshift to Metastasize

Research indicates that cancer cells possess significant plasticity, enabling them to alter their cellular state to adapt to their environment during metastasis. Instead of spreading in their existing form, these cells can transition into different states, such as a stem-cell state or assume alternative fates, as explained by Dr. Tanvi.

Investigating the potential of blocking the ZFP36L2 protein as a strategy to prevent metastatic dissemination in colorectal cancer, researchers note its dual role. While blocking ZFP36L2 could impede metastatic seeding, its importance in tissue repair presents an obstacle. Additionally, cancer cells might develop compensatory mechanisms to overcome the loss of this protein by adopting new cell fates.

This study represents a crucial advancement in understanding metastasis, though translating these laboratory findings into clinical therapy requires more investigation. It remains uncertain if ZFP36L2 can be safely and selectively inhibited in patients and what the impact on patient outcomes would be. Current colorectal cancer treatments should continue to rely on established clinical evidence rather than these preclinical findings.